Search - tctmd.com

Displaying 621 - 640 of 665

Sort: Relevancy | Date

Presentation

Sex Differences in Mortality After TAVR for Severe Aortic Stenosis

Presenter: Karin H. Humphries

July 18, 2012

Presentation TCTAP 2012

Everolimus-Eluting Stent Implantation for Unprotected Left Main Stenosis:

Presenter: Young-Hak Kim

April 26, 2012

News Daily News

PCI for Left Main Disease Uncommon in US Clinical Practice

Jason Kahn

March 23, 2012

News Daily News

La PCI contra la Enfermedad del Tronco Coronario Izquierdo es Poco Frecuente en la Práctica Clínica de EE.UU

Jason Kahn

March 23, 2012

News Daily News

Drug-Eluting Balloon Continues Strong Showing in SFA Lesions

Jason Kahn

March 22, 2012

News Daily News

TCTMD’s Top 10 Most Popular News Stories From 2011

Jason Kahn

March 08, 2012

News Daily News

Restenotic Pattern After Femoropopliteal Stenting Predicts Recurrence

March 06, 2012

News Daily News

CREST Analysis: Restenosis Rates Similar at 2 Years for Carotid Stenting, Surgery

Caitlin E. Cox

March 06, 2012

Presentation

Characteristics and Long-term Outcomes of Percutaneous Revascularization of Unprotected Left Main Coronary Artery Stenosis in the United States

Presenter: J. Matthew Brennan

February 05, 2012

News Daily News

New Revascularization Appropriateness Criteria Feature PCI Upgrades

January 31, 2012

News Daily News

Women Benefit From TAVR as Much as Men, Maybe More

Jason Kahn

January 29, 2012

News Daily News

PROFI Published: Better Cerebral Protection with Balloon Occlusion after CAS

Yael L. Maxwell

January 25, 2012

Presentation TCT 2012

5-year results of treatment of Unprotected Left Main Stenosis by CABG or PCI with Sirolimus eluting stent. A multicenter, randomized trial

Presenter: Enno Boudriot, Holger Thiele, Franz J. Neumann, Michael Gick, Bruno Reichard, Peter Boekstegers, Harald Mudra, Florian Beier, Thomas Walther, Friedrich W. Mohr, Gerhard Schuler

January 03, 2012

News Daily News

Balloon Occlusion Bests Filter in Cerebral Protection After Carotid Stenting

Yael L. Maxwell

November 28, 2011

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Daily News

FFR Guides Therapy for Proximal LAD Lesions

Jason Kahn

October 26, 2011

News Daily News

FDA, CMS Parallel Review Aims to Speed Access to Innovative Technologies

L.A. McKeown

October 14, 2011

News Daily News

More CREST Controversy: How Relevant Is Age in Treatment Decisions?

L.A. McKeown

October 11, 2011

News Daily News

Incomplete Revascularization Linked With Mortality in Multivessel Disease Patients

Yael L. Maxwell

October 11, 2011

Advertisement

Sex Differences in Mortality After TAVR for Severe Aortic Stenosis

Everolimus-Eluting Stent Implantation for Unprotected Left Main Stenosis:

PCI for Left Main Disease Uncommon in US Clinical Practice

La PCI contra la Enfermedad del Tronco Coronario Izquierdo es Poco Frecuente en la Práctica Clínica de EE.UU

Drug-Eluting Balloon Continues Strong Showing in SFA Lesions

TCTMD’s Top 10 Most Popular News Stories From 2011

Restenotic Pattern After Femoropopliteal Stenting Predicts Recurrence

CREST Analysis: Restenosis Rates Similar at 2 Years for Carotid Stenting, Surgery

Characteristics and Long-term Outcomes of Percutaneous Revascularization of Unprotected Left Main Coronary Artery Stenosis in the United States

New Revascularization Appropriateness Criteria Feature PCI Upgrades

Women Benefit From TAVR as Much as Men, Maybe More

PROFI Published: Better Cerebral Protection with Balloon Occlusion after CAS

5-year results of treatment of Unprotected Left Main Stenosis by CABG or PCI with Sirolimus eluting stent. A multicenter, randomized trial

Balloon Occlusion Bests Filter in Cerebral Protection After Carotid Stenting

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

FFR Guides Therapy for Proximal LAD Lesions

FDA, CMS Parallel Review Aims to Speed Access to Innovative Technologies

More CREST Controversy: How Relevant Is Age in Treatment Decisions?

Incomplete Revascularization Linked With Mortality in Multivessel Disease Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content